Literature DB >> 8540694

Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage.

B Currie1, H Sanati, A S Ibrahim, J E Edwards, A Casadevall, M A Ghannoum.   

Abstract

Previous studies have shown that sequential isolates from patients with persistent Cryptococcus neoformans meningoencephalitis can vary in sterol composition and susceptibility to antifungal drugs. To investigate the potential of host factors as mediators of this phenomenon, we compared fungal susceptibilities of environmental and clinical isolates from a limited geographic area. Clinical isolates were less susceptible to amphotericin B than environmental isolates. Five environmental isolates were passaged through BALB/c murine hosts; the passaged isolates had changes in sterol composition and reduced amphotericin B susceptibilities relative to those of the parent isolates. In contrast, murine passage of these isolates did not alter their susceptibilities to fluconazole. The results confirm that changes in sterol composition and antifungal susceptibility can occur in vivo as a result of host factors and suggest that human infection can result in selection of variants with reduced susceptibilities to amphotericin B.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8540694      PMCID: PMC162859          DOI: 10.1128/AAC.39.9.1934

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors:  M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal:  N Engl J Med       Date:  1992-01-09       Impact factor: 91.245

Review 2.  Amphotericin B: current understanding of mechanisms of action.

Authors:  J Brajtburg; W G Powderly; G S Kobayashi; G Medoff
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 3.  Fluconazole, a new antifungal agent.

Authors:  J N Galgiani
Journal:  Ann Intern Med       Date:  1990-08-01       Impact factor: 25.391

4.  Maintenance amphotericin B for cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS).

Authors:  A Zuger; M Schuster; M S Simberkoff; J J Rahal; R S Holzman
Journal:  Ann Intern Med       Date:  1988-10-01       Impact factor: 25.391

5.  Reference high-efficiency nonpolar packed columns for the gas-liquid chromatography of nanogram amounts of steroids. I. Retention time data.

Authors:  F A Vandenheuvel; A S Court
Journal:  J Chromatogr       Date:  1968-12-17

6.  In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.

Authors:  J E Wolf; S E Massof
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Persistence of initial infection in recurrent Cryptococcus neoformans meningitis.

Authors:  E D Spitzer; S G Spitzer; L F Freundlich; A Casadevall
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

8.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Susceptibility testing of Cryptococcus neoformans: a microdilution technique.

Authors:  M A Ghannoum; A S Ibrahim; Y Fu; M C Shafiq; J E Edwards; R S Criddle
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

10.  Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Authors:  B P Currie; A Casadevall
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

View more
  21 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 2.  Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans.

Authors:  Neena Jain; Abraham Guerrero; Bettina C Fries
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

3.  Effects of antifungal interventions on the outcome of experimental infections with phenotypic switch variants of Cryptococcus neoformans.

Authors:  Bettina C Fries; Emily Cook; Xiabo Wang; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.

Authors:  Neena Jain; Li Li; Ye-Ping Hsueh; Abraham Guerrero; Joseph Heitman; David L Goldman; Bettina C Fries
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

Review 5.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

6.  Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure.

Authors:  B C Fries; D L Goldman; R Cherniak; R Ju; A Casadevall
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

7.  Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.

Authors:  B C Fries; C P Taborda; E Serfass; A Casadevall
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

8.  In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.

Authors:  W Cleare; R Cherniak; A Casadevall
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

9.  Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents.

Authors:  D L Goldman; B C Fries; S P Franzot; L Montella; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

10.  Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray.

Authors:  Peter R Kraus; Marie-Josée Boily; Steven S Giles; Jason E Stajich; Andria Allen; Gary M Cox; Fred S Dietrich; John R Perfect; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.